138 related articles for article (PubMed ID: 12445546)
1. Cryosurgical ablation of liver tumors in colon cancer patients increases the serum total ganglioside level and then selectively augments antiganglioside IgM.
Ravindranath MH; Wood TF; Soh D; Gonzales A; Muthugounder S; Perez C; Morton DL; Bilchik AJ
Cryobiology; 2002 Aug; 45(1):10-21. PubMed ID: 12445546
[TBL] [Abstract][Full Text] [Related]
2. Gangliosides as targets for immunotherapy for pancreatic adenocarcinoma.
Chu KU; Ravindranath MH; Gonzales A; Nishimoto K; Tam WY; Soh D; Bilchik A; Katopodis N; Morton DL
Cancer; 2000 Apr; 88(8):1828-36. PubMed ID: 10760759
[TBL] [Abstract][Full Text] [Related]
3. Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications.
Perez CA; Ravindranath MH; Soh D; Gonzales A; Ye W; Morton DL
Cancer J; 2002; 8(5):384-94. PubMed ID: 12416896
[TBL] [Abstract][Full Text] [Related]
4. Human antiganglioside autoantibodies: validation of ELISA.
Ravindranath MH; Muthugounder S; Saravanan TS; Presser N; Morton DL
Ann N Y Acad Sci; 2005 Jun; 1050():229-42. PubMed ID: 16014538
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, specificity and functionality of anti-ganglioside antibodies in neuropathy associated with IgM monoclonal gammopathy.
Stork AC; Jacobs BC; Tio-Gillen AP; Eurelings M; Jansen MD; van den Berg LH; Notermans NC; van der Pol WL
J Neuroimmunol; 2014 Mar; 268(1-2):89-94. PubMed ID: 24529728
[TBL] [Abstract][Full Text] [Related]
6. Significance of endogenous augmentation of antiganglioside IgM in cancer patients: potential tool for early detection and management of cancer therapy.
Ravindranath MH; Muthugounder S; Hannah MR; Morton DL
Ann N Y Acad Sci; 2007 Jun; 1107():212-22. PubMed ID: 17804549
[TBL] [Abstract][Full Text] [Related]
7. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
8. Attachment of monophosphoryl lipid A (MPL) to cells and liposomes augments antibody response to membrane-bound gangliosides.
Ravindranath MH; Morton DL; Irie RF
J Autoimmun; 1994 Dec; 7(6):803-16. PubMed ID: 7888037
[TBL] [Abstract][Full Text] [Related]
9. Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.
Ragupathi G; Meyers M; Adluri S; Howard L; Musselli C; Livingston PO
Int J Cancer; 2000 Mar; 85(5):659-66. PubMed ID: 10699946
[TBL] [Abstract][Full Text] [Related]
10. Immunology of gangliosides.
Ravindranath MH; Gonzales AM; Nishimoto K; Tam WY; Soh D; Morton DL
Indian J Exp Biol; 2000 Apr; 38(4):301-12. PubMed ID: 11218805
[TBL] [Abstract][Full Text] [Related]
11. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
12. Monitoring response to treatment in melanoma patients: potential of a serum glycomic marker.
Selvan SR; Dillman RO; Fowler AW; Carbonell DJ; Ravindranath MH
Int J Cancer; 2008 Mar; 122(6):1374-83. PubMed ID: 17960619
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against gangliosides in patients with dementia.
Hatzifilippou E; Koutsouraki E; Costa VG; Baloyannis SJ
Am J Alzheimers Dis Other Demen; 2014 Dec; 29(8):660-6. PubMed ID: 24838532
[TBL] [Abstract][Full Text] [Related]
14. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
15. Incidental presence of antibodies against gangliosides in Graves' disease.
Adler G; Pacuszka T; Targonska I; Lewartowska A; Nauman J
Autoimmunity; 1994; 18(2):149-52. PubMed ID: 7742477
[TBL] [Abstract][Full Text] [Related]
16. Anti-GD2-like IgM autoreactivity in multiple sclerosis patients.
Marconi S; Acler M; Lovato L; De Toni L; Tedeschi E; Anghileri E; Romito S; Cordioli C; Bonetti B
Mult Scler; 2006 Jun; 12(3):302-8. PubMed ID: 16764343
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of melanoma-associated gangliosides in cancer patients.
Tai T; Cahan LD; Tsuchida T; Saxton RE; Irie RF; Morton DL
Int J Cancer; 1985 May; 35(5):607-12. PubMed ID: 3997282
[TBL] [Abstract][Full Text] [Related]
18. Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21.
Ragupathi G; Livingston PO; Hood C; Gathuru J; Krown SE; Chapman PB; Wolchok JD; Williams LJ; Oldfield RC; Hwu WJ
Clin Cancer Res; 2003 Nov; 9(14):5214-20. PubMed ID: 14614001
[TBL] [Abstract][Full Text] [Related]
19. Endogenous immune response to gangliosides in patients with confined prostate cancer.
Ravindranath MH; Muthugounder S; Presser N; Ye X; Brosman S; Morton DL
Int J Cancer; 2005 Sep; 116(3):368-77. PubMed ID: 15818621
[TBL] [Abstract][Full Text] [Related]
20. Calreticulin is a B cell molecular target in some gastrointestinal malignancies.
Pekáriková A; Sánchez D; Palová-Jelínková L; Simsová M; Benes Z; Hoffmanová I; Drastich P; Janatková I; Mothes T; Tlaskalová-Hogenová H; Tucková L
Clin Exp Immunol; 2010 May; 160(2):215-22. PubMed ID: 20030668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]